Consensus projects Johnson & Johnson's EPS CAGR of 8.9% (2026–2030), with forward P/E compressing from 20.8x to 14.8x. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results